Carotid intima–media thickness: A suitable alternative for cardiovascular risk as outcome?

European Journal of Preventive Cardiology

Volumn 18, Issue 2, 2011, Pages 167-174

  Peters, Sanne Ae ^a   Grobbee, Diederick E ^a   Bots, Michiel L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

atherosclerosis; B mode ultrasound; cardiovascular disease; Carotid intima media thickness; prevention

Indexed keywords

ARTERIAL WALL THICKNESS; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; DISEASE MARKER; DISEASE SEVERITY; HUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; RISK FACTOR;

CAROTID ARTERIES; CAROTID ARTERY DISEASES; DISEASE PROGRESSION; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 79959234136     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/1741826710389400     Document Type: Article

References (83)

1. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74(6): 1399–1406.
2. Powers, JH. Surrogate endpoints in infectious diseases trials: FDA perspective, http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM187274.ppt 2009, consulted November 2009.
3. Bots ML, Evans GW, Riley WA, Grobbee DE. Carotid intima–media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Stroke 2003; 34(12): 2985–2994.
4. Geerts CC, Bots ML, Grobbee DE, Uiterwaal CS. Parental smoking and vascular damage in young adult offspring: is early life exposure critical? The atherosclerosis risk in young adults study. Arterioscler Thromb Vasc Biol 2008; 28(12): 2296–2302.
5. Plantinga Y, Dogan S, Grobbee DE, Bots ML. Carotid intima–media thickness measurement in cardiovascular screening programmes. Eur J Cardiovasc Prev Rehabil 2009; 16(6): 639–644.
6. Hulten E, Mitchell J, Scally J, Gibbs B, Villines TC. HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies. Heart 2009; 95(22): 1826–1835.
7. van Oijen M, de Jong FJ, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM. Atherosclerosis and risk for dementia. Ann Neurol 2007; 61(5): 403–410.
8. Prentice RL. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 1989; 8(4): 431–440.
9. Wong M, Edelstein J, Wollman J, Bond MG. Ultrasonic-pathological comparison of the human arterial wall. Verification of intima–media thickness. Arterioscler Thromb 1993; 13(4): 482–486.
10. Gamble G, Beaumont B, Smith H, et al. B-mode ultrasound images of the carotid artery wall: correlation of ultrasound with histological measurements. Atherosclerosis 1993; 102(2): 163–173.
11. Bots ML, de Jong PT, Hofman A, Grobbee DE. Left, right, near or far wall common carotid intima–media thickness measurements: associations with cardiovascular disease and lower extremity arterial atherosclerosis. J Clin Epidemiol 1997; 50(7): 801–807.
12. Furberg CD, Byington RP, Craven TE. Lessons learned from clinical trials with ultrasound end-points. J Intern Med 1994; 236(5): 575–580.
13. Kanters SD, Algra A, van Leeuwen MS, Banga JD. Reproducibility of in vivo carotid intima–media thickness measurements: a review. Stroke 1997; 28(3): 665–671.
14. Dogan S, Plantinga Y, Dijk JM, van der GY, Grobbee DE, Bots ML. Manual B-mode versus automated radio-frequency carotid intima–media thickness measurements. J Am Soc Echocardiogr 2009; 22(10): 1137–1144.
15. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima–media thickness: a systematic review and meta-analysis. Circulation 2007; 30; 115(4): 459–467.
16. Bots ML, Mulder PG, Hofman A, van Es GA, Grobbee DE. Reproducibility of carotid vessel wall thickness measurements. The Rotterdam Stud. J Clin Epidemiol 1994; 47(8): 921–930.
17. O’Leary DH, Polak JF, Wolfson SK Jr, et al. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 1991; 22(9): 1155–1163.
18. Riley WA, Barnes RW, Applegate WB, et al. Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis. The Asymptomatic Carotid Artery Plaque Study. Stroke 1992; 23(8): 1062–1068.
19. Salonen R, Haapanen A, Salonen JT. Measurement of intima–media thickness of common carotid arteries with high-resolution B-mode ultrasonography: inter- and intra-observer variability. Ultrasound Med Biol 1991; 17(3): 225–230.
20. Furberg CD, Adams HP Jr, Applegate WB, et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation 1994; 90(4): 1679–1687.
21. Bots ML, Evans GW, Riley W, et al. The Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study: design and baseline characteristics. Control Clin Trials 2003; 24(6): 752–775.
22. Crouse JR III, Grobbee DE, O’Leary DH, et al. Carotid intima–media thickness in low-risk individuals with asymptomatic atherosclerosis: baseline data from the METEOR study. Curr Med Res Opin 2007; 23(3): 641–648.
23. Kastelein JJ, van Leuven SI, Evans GW, et al. Designs of RADIANCE 1 and 2: carotid ultrasound studies comparing the effects of torcetrapib/atorvastatin with atorvastatin alone on atherosclerosis. Curr Med Res Opin 2007; 23(4): 885–894.
24. Handa N, Matsumoto M, Maeda H, et al. Ultrasonic evaluation of early carotid atherosclerosis. Stroke 1990; 21(11): 1567–1572.
25. Dempsey RJ, Moore RW. Amount of smoking independently predicts carotid artery atherosclerosis severity. Stroke 1992; 23(5): 693–696.
26. Bots ML, Hofman A, de Bruyn AM, de Jong PT, Grobbee DE. Isolated systolic hypertension and vessel wall thickness of the carotid artery. The Rotterdam Elderly Study. Arterioscler Thromb 1993; 13(1): 64–69.
27. Psaty BM, Furberg CD, Kuller LH, et al. Isolated systolic hypertension and subclinical cardiovascular disease in the elderly. Initial findings from the Cardiovascular Health Study. JAMA 1992; 268(10): 1287–1291.
28. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991; 134(3): 250–256.
29. Salonen R, Salonen JT. Determinants of carotid intima–media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 1991; 229(3): 225–231.
30. Bonithon-Kopp C, Scarabin PY, Taquet A, Touboul PJ, Malmejac A, Guize L. Risk factors for early carotid atherosclerosis in middle-aged French women. Arterioscler Thromb 1991; 11(4): 966–972.
31. Prati P, Vanuzzo D, Casaroli M, et al. Prevalence and determinants of carotid atherosclerosis in a general population. Stroke 1992; 23(12): 1705–1711.
32. O’Leary DH, Polak JF, Kronmal RA, et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke 1992; 23(12): 1752–1760.
33. el-Barghouti N, Elkeles R, Nicolaides A, Geroulakos G, Dhanjil S, Diamond J. The ultrasonic evaluation of the carotid intima–media thickness and its relation to risk factors of atherosclerosis in normal and diabetic population. Int Angiol 1997; 16(1): 50–54.
34. Geroulakos G, O’Gorman DJ, Kalodiki E, Sheridan DJ, Nicolaides AN. The carotid intima–media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J 1994; 15(6): 781–785.
35. Ebrahim S, Papacosta O, Whincup P, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 1999; 30(4): 841–850.
36. Persson J, Formgren J, Israelsson B, Berglund G. Ultrasound-determined intima–media thickness and atherosclerosis. Direct and indirect validation. Arterioscler Thromb 1994; 14(2): 261–264.
37. Zanchetti A, Crepaldi G, Bond MG, et al. Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima–media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lowering Italian Study. PHYLLIS study group. J Hypertens 2001; 19(1): 79–88.
38. Pauletto P, Palatini P, Da RS, et al. Factors underlying the increase in carotid intima–media thickness in borderline hypertensives. Arterioscler Thromb Vasc Biol 1999; 19(5): 1231–1237.
39. Bots ML, Dijk JM, Oren A, Grobbee DE. Carotid intima–media thickness, arterial stiffness and risk of cardiovascular disease: current evidence. J Hypertens 2002; 20(12): 2317–2325.
40. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima–media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002; 20(2): 159–169.
41. Sakurai S, Kitamura A, Cui R, Yamagishi K, Tanigawa T, Iso H. Relationships of soluble E-selectin and high-sensitivity C-reactive protein with carotid atherosclerosis in Japanese men. J Atheroscler Thromb 2009; 16(4): 339–345.
42. Baldassarre D, De JA, Amato M, et al. Carotid intima–media thickness and markers of inflammation, endothelial damage and hemostasis. Ann Med 2008; 40(1): 21–44.
43. Bots ML, van Swieten JC, Breteler MM, et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet 1993; 341(8855): 1232–1237.
44. Crouse JR III, Craven TE, Hagaman AP, Bond MG. Association of coronary disease with segment-specific intimal–medial thickening of the extracranial carotid artery. Circulation 1995; 92(5): 1141–1147.
45. Davis PH, Dawson JD, Mahoney LT, Lauer RM. Increased carotid intimal–medial thickness and coronary calcification are related in young and middle-aged adults. The Muscatine study. Circulation 1999; 100(8): 838–842.
46. Linhart A, Gariepy J, Giral P, Levenson J, Simon A. Carotid artery and left ventricular structural relationship in asymptomatic men at risk for cardiovascular disease. Atherosclerosis 1996; 127(1): 103–112.
47. Cuspidi C, Lonati L, Sampieri L, Leonetti G, Zanchetti A. Similarities and differences in structural and functional changes of left ventricle and carotid arteries in young borderline hypertensives and in athletes. J Hypertens 1996; 14(6): 759–764.
48. Cuspidi C, Lonati L, Sampieri L, et al. Left ventricular concentric remodelling and carotid structural changes in essential hypertension. J Hypertens 1996; 14(12): 1441–1446.
49. Mykkanen L, Zaccaro DJ, O’Leary DH, Howard G, Robbins DC, Haffner SM. Microalbuminuria and carotid artery intima–media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS). Stroke 1997; 28(9): 1710–1716.
50. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima–media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997; 96(5): 1432–1437.
51. Hashimoto M, Eto M, Akishita M, et al. Correlation between flow–mediated vasodilatation of the brachial artery and intima–media thickness in the carotid artery in men. Arterioscler Thromb Vasc Biol 1999; 19(11): 2795–2800.
52. Polak JF, O’Leary DH, Kronmal RA, et al. Sonographic evaluation of carotid artery atherosclerosis in the elderly: relationship of disease severity to stroke and transient ischemic attack. Radiology 1993; 188(2): 363–370.
53. Howard G, Burke GL, Evans GW, et al. Relations of intimal–medial thickness among sites within the carotid artery as evaluated by B-mode ultrasound. ARIC Investigators. Atherosclerosis Risk in Communities. Stroke 1994; 25(8): 1581–1587.
54. Bots ML, Hofman A, de Jong PT, Grobbee DE. Common carotid intima–media thickness as an indicator of atherosclerosis at other sites of the carotid artery. The Rotterdam Study. Ann Epidemiol 1996; 6(2): 147–153.
55. Bots ML, Witteman JC, Grobbee DE. Carotid intima–media wall thickness in elderly women with and without atherosclerosis of the abdominal aorta. Atherosclerosis 1993; 102(1): 99–105.
56. Bots ML, Hofman A, Grobbee DE. Common carotid intima–media thickness and lower extremity arterial atherosclerosis. The Rotterdam Study. Arterioscler Thromb 1994; 14(12): 1885–1891.
57. Allan PL, Mowbray PI, Lee AJ, Fowkes FG. Relationship between carotid intima–media thickness and symptomatic and asymptomatic peripheral arterial disease. The Edinburgh Artery Study. Stroke 1997; 28(2): 348–353.
58. Bots ML, Baldassarre D, Simon A, et al. Carotid intima–media thickness and coronary atherosclerosis: weak or strong relations? Eur Heart J 2007; 28(4): 398–406.
59. Ogata T, Yasaka M, Yamagishi M, Seguchi O, Nagatsuka K, Minematsu K. Atherosclerosis found on carotid ultrasonography is associated with atherosclerosis on coronary intravascular ultrasonography. J Ultrasound Med 2005; 24(4): 469–474.
60. Aboyans V, Kamineni A, Allison MA, et al. The epidemiology of subclavian stenosis and its association with markers of subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2010; 211(1): 266–270.
61. Dijk JM, van der GY, Bots ML, Grobbee DE, Algra A. Carotid intima–media thickness and the risk of new vascular events in patients with manifest atherosclerotic disease: the SMART study. Eur Heart J 2006; 27(16): 1971–1978.
62. Salonen R, Salonen JT. Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Atherosclerosis 1990; 81(1): 33–40.
63. Chambless LE, Folsom AR, Davis V, et al. Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987–1998. Am J Epidemiol 2002; 155(1): 38–47.
64. Mackinnon AD, Jerrard-Dunne P, Sitzer M, Buehler A, von Kegler S, Markus H.S. Rates and determinants of site-specific progression of carotid artery intima–media thickness: the carotid atherosclerosis progression study. Stroke 2004; 35(9): 2150–2154.
65. van der Meer I, Iglesias del SA, Hak AE, Bots ML, Hofman A, Witteman JC. Risk factors for progression of atherosclerosis measured at multiple sites in the arterial tree: the Rotterdam Study. Stroke 2003; 34(10): 2374–2379.
66. Yanez ND III, Kronmal RA, Shemanski LR, Psaty BM. A regression model for longitudinal change in the presence of measurement error. Ann Epidemiol 2002; 12(1): 34–38.
67. Espeland MA, O’Leary DH, Terry JG, Morgan T, Evans G, Mudra H. Carotid intimal–media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr Control Trials Cardiovasc Med 2005; 6(1): 3–3.
68. Amarenco P, Labreuche J, Lavallee P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 2004; 35(12): 2902–2909.
69. Smilde TJ, van WS, Wollersheim H, Trip MD, Kastelein JJ, Stalenhoef AF. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet 2001; 357(9256): 577–581.
70. Taylor AJ, Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Vernalis MN. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation 2002; 106(16): 2055–2060.
71. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004; 291(9): 1071–1080.
72. Kastelein JJ, van Leuven SI, Burgess L, et al. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med 2007; 356(16): 1620–1630.
73. Bots ML, Visseren FL, Evans GW, et al. Torcetrapib and carotid intima–media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial. Lancet 2007; 370(9582): 153–160.
74. Barter PJ, Caulfield M, Eriksson M, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007; 357(21): 2109–2122.
75. Wang JG, Staessen JA, Li Y, et al. Carotid intima–media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials. Stroke 2006; 37(7): 1933–1940.
76. Yokoyama H, Katakami N, Yamasaki Y. Recent advances of intervention to inhibit progression of carotid intima–media thickness in patients with type 2 diabetes mellitus. Stroke 2006; 37(9): 2420–2427.
77. Hodis HN, Mack WJ, LaBree L, et al. The role of carotid arterial intima–media thickness in predicting clinical coronary events. Ann Intern Med 1998; 128(4): 262–269.
78. Costanzo P, Perrone-Filardi P, Vassallo E, Paolille S, Cesarano P, Chiareollo M. Prediction of cardiovascular events by drug induced changes in carotid intima media thickness. A meta-analysis of 41 randomized trials. Eur Heart J 2010; 31(Abstract Supplement): 148–148.
79. Lorenz MW, Bickel H, Bots ML, et al. Individual progression of carotid intima media thickness as a surrogate for vascular risk (PROG-IMT): Rationale and design of a meta-analysis project. Am Heart J 2010; 159(5): 730–736.
80. Bots ML, Hofman A, Grobbee DE. Increased common carotid intima–media thickness. Adaptive response or a reflection of atherosclerosis? Findings from the Rotterdam Study. Stroke 1997; 28(12): 2442–2447.
81. Finn AV, Kolodgie FD, Virmani R. Correlation between carotid intimal/medial thickness and atherosclerosis. A point of view from pathology. Arterioscler Thromb Vasc Biol 2009; 30(2): 177–181.
82. Spence JD, Eliasziw M, DiCicco M, Hackam DG, Galil R, Lohmann T. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke 2002; 33(12): 2916–2922.
83. Rundek T, Arif H, Boden-Albala B, Elkind MS, Paik MC, Sacco RL. Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study. Neurology 2008; 70(14): 1200–1207.